GLUT1 protein levels are much higher in tumor tissues than in normal tissue and correlate with clinic-pathologic variables in different patient cohorts, implying that GLUT1 is both a prognostic and diagnostic marker for EC patients [42]. This evidence concerns the gene SLC2A1 and neoplasm.